Position
Chief Technical Officer
Company
Crispr Therapeutics
ZugBiotechnologyHealthcareHealth CareGeneticsTherapeuticsDescription
Sivakesava Sakhamuri became Chief Technical Officer of Crispr Therapeutics on November 2, 2026, per the SEC Form 3 filed November 2, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Quick answer
Crispr Therapeutics Names Sivakesava Sakhamuri Chief Technical Officer (November 3, 2026). Crispr Therapeutics is based in Zug, Zug, Switzerland.
- Who is the new Chief Technical Officer at Crispr Therapeutics?
- Crispr Therapeutics named Sivakesava Sakhamuri Chief Technical Officer, announced November 3, 2026.
- What did Crispr Therapeutics announce on November 3, 2026?
- Sivakesava Sakhamuri became Chief Technical Officer of Crispr Therapeutics on November 2, 2026, per the SEC Form 3 filed November 2, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
- What does Crispr Therapeutics do?
- CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
- Where is Crispr Therapeutics based?
- Crispr Therapeutics is based in Zug, Zug, Switzerland.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Tempest Therapeutics (November 4, 2026), Change Agents Corporation. (November 5, 2026) and Azora Therapeutics, Inc. (DE) (October 31, 2026) also announced leadership changes within 45 days of Crispr Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Genetics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Tempest Therapeutics names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec. (November 4, 2026)
- Change Agents Corporation Appoints Luisa Ingargiola as Principal Executive Officer (November 5, 2026)
- Adial Pharmaceuticals names Julie Saiki Chief Strategy Officer (October 31, 2026)
- Grant C. Bogle Appointed as Class III Director at Immuneering Corporation (November 9, 2026)
- Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer (November 13, 2026)
Who to call at Crispr Therapeutics, and when
A new leader at Crispr Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Crispr Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crispr Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crispr Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crispr Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Crispr Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.